The impact of membrane permeability and dialysate purity on cardiovascular outcomes.
Asci G, Tz H, Ozkahya M, Duman S, Demirci MS, Cirit M, Sipahi S, Dheir H, Bozkurt D, Kircelli F, Ok ES, Erten S, Ertilav M, Kose T, Basci A, Raimann JG, Levin NW, Ok E; EGE Study Group.
Asci G, et al.
J Am Soc Nephrol. 2013 May;24(6):1014-23. doi: 10.1681/ASN.2012090908. Epub 2013 Apr 25.
J Am Soc Nephrol. 2013.
PMID: 23620396
Free PMC article.
Clinical Trial.